Security record · archived quarter
OMCL
Omnicell, Inc. · Healthcare · Medical - Healthcare Information Services
13Tracked holders
—Δ holders
3.69MShares held
$99.83MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 99 | +2 | 36.97M | $1.52B | +8 | −6 |
| Q1 2026 | 100 | +1 | 36.98M | $1.23B | +6 | −5 |
| Q4 2025 | 99 | +2 | 40.13M | $1.82B | +2 | — |
| Q3 2025 | 18 | 0 | 22.98M | $699.67M | +1 | −1 |
| Q2 2025 | 15 | -1 | 21.34M | $627.32M | +1 | −2 |
| Q1 2025 | 13 | -1 | 6.74M | $235.79M | — | −1 |
| Q4 2024 | 14 | +1 | 6.20M | $275.97M | +1 | — |
| Q3 2024 | 12 | -1 | 3.89M | $169.70M | — | −1 |
| Q2 2024 | 13 | — | 3.69M | $99.83M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.10M | — | $29.83M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.10M | — | $29.83M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 1.09M | — | $29.45M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 1.09M | — | $29.45M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 1.09M | — | $29.45M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 418.39K | — | $11.33M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 418.39K | — | $11.33M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 418.39K | — | $11.33M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 418.39K | — | $11.33M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 418.39K | — | $11.33M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 389.64K | — | $10.55M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 131.30K | — | $3.55M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 123.89K | — | $3.35M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | PRIMECAP Management ✦ | 110.77K | — | $3.00M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Millennium Management ✦ | 97.00K | — | $2.63M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Millennium Management ✦ | 97.00K | — | $2.63M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 59.97K | — | $1.62M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 59.97K | — | $1.62M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 49.07K | — | $1.33M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 49.07K | — | $1.33M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 40.45K | — | $1.09M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 39.31K | — | $1.06M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 38.29K | — | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2 holders, 5.77M shares, $5.60M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API